Penumbra, Inc. (BMV:PEN)

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013
United States Revenue	1.04B	902.07M	757.15M
United States Revenue Growth	15.36%	19.14%	27.96%
International Revenue	293.17M	292.55M	301.37M
International Revenue Growth	0.21%	-2.93%	17.99%
Revenue (Total)	1.33B	1.19B	1.06B
Revenue (Total) Growth	11.65%	12.86%	24.95%

Revenue Breakdown

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013
Thrombectomy Revenue	913.35M	815.48M	677.34M
Thrombectomy Revenue Growth	12.00%	20.39%	32.52%
Embolization and Access Revenue	420.45M	379.14M	381.18M
Embolization and Access Revenue Growth	10.90%	-0.53%	13.45%
Revenue (Total)	1.33B	1.19B	1.06B
Revenue (Total) Growth	11.65%	12.86%	24.95%

Revenue Breakdown 2

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013
Vascular Revenue	-	-	652.45M
Vascular Revenue Growth	-	-	30.65%
Neuro Revenue	-	-	406.08M
Neuro Revenue Growth	-	-	16.77%
Revenue (Total)	1.33B	1.19B	1.06B
Revenue (Total) Growth	11.65%	12.86%	24.95%

Updated Sep 30, 2025. Data Source: Fiscal.ai.